PL405911A1 - Białko o aktywności hydrolitycznej wobec polisacharydowych otoczek bakteryjnych, polinukleotyd kodujący to białko, biologicznie czynny wektor, kompozycja zawierająca białko i jego zastosowanie - Google Patents

Białko o aktywności hydrolitycznej wobec polisacharydowych otoczek bakteryjnych, polinukleotyd kodujący to białko, biologicznie czynny wektor, kompozycja zawierająca białko i jego zastosowanie

Info

Publication number
PL405911A1
PL405911A1 PL40591113A PL40591113A PL405911A1 PL 405911 A1 PL405911 A1 PL 405911A1 PL 40591113 A PL40591113 A PL 40591113A PL 40591113 A PL40591113 A PL 40591113A PL 405911 A1 PL405911 A1 PL 405911A1
Authority
PL
Poland
Prior art keywords
protein
hydrolytic activity
applications
composition containing
biologically active
Prior art date
Application number
PL40591113A
Other languages
English (en)
Inventor
Ewa Brzozowska
Krzysztof Pawlik
Sabina Górska
Andrzej Gamian
Original Assignee
Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością filed Critical Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL40591113A priority Critical patent/PL405911A1/pl
Priority to PCT/PL2014/000126 priority patent/WO2015065209A1/en
Publication of PL405911A1 publication Critical patent/PL405911A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10211—Podoviridae
    • C12N2795/10222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Przedmiotem wynalazku są białka ogonkowe bakteriofaga Klebsiella pneumoniae KP32, uzyskane drogą rekombinacji wykazujące aktywność hydrolityczną w stosunku do polisacharydowych otoczek bakteryjnych. Białka o sekwencjach aminokwasowych oznaczonych SEKW NR 1 - gp31 i SEKW NR 2 - gp32 przeciwdziałają powstawaniu i degradują biofilm tworzony przez szczepy Klebsiella pneumoniae oraz wykazują synergistyczne działanie w zwalczaniu biofilmu tworzonego przez szczepy K.pneumoniae, E.cloacae i S.aureus.
PL40591113A 2013-11-04 2013-11-04 Białko o aktywności hydrolitycznej wobec polisacharydowych otoczek bakteryjnych, polinukleotyd kodujący to białko, biologicznie czynny wektor, kompozycja zawierająca białko i jego zastosowanie PL405911A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL40591113A PL405911A1 (pl) 2013-11-04 2013-11-04 Białko o aktywności hydrolitycznej wobec polisacharydowych otoczek bakteryjnych, polinukleotyd kodujący to białko, biologicznie czynny wektor, kompozycja zawierająca białko i jego zastosowanie
PCT/PL2014/000126 WO2015065209A1 (en) 2013-11-04 2014-11-04 Protein having hydrolytic activity against bacterial polysaccharide capsules, polynucleotide encoding this protein, biologically active vector, composition containing the protein and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL40591113A PL405911A1 (pl) 2013-11-04 2013-11-04 Białko o aktywności hydrolitycznej wobec polisacharydowych otoczek bakteryjnych, polinukleotyd kodujący to białko, biologicznie czynny wektor, kompozycja zawierająca białko i jego zastosowanie

Publications (1)

Publication Number Publication Date
PL405911A1 true PL405911A1 (pl) 2015-05-11

Family

ID=52101558

Family Applications (1)

Application Number Title Priority Date Filing Date
PL40591113A PL405911A1 (pl) 2013-11-04 2013-11-04 Białko o aktywności hydrolitycznej wobec polisacharydowych otoczek bakteryjnych, polinukleotyd kodujący to białko, biologicznie czynny wektor, kompozycja zawierająca białko i jego zastosowanie

Country Status (2)

Country Link
PL (1) PL405911A1 (pl)
WO (1) WO2015065209A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113755469B (zh) * 2021-11-09 2022-02-22 上海瑞宙生物科技有限公司 肺炎克雷伯菌荚膜多糖解聚酶及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822740A (en) 1985-10-07 1989-04-18 Microlife Technics, Inc. Bacteria for expressing a polysaccharide depolymerase containing a novel recombinant plasmid
EP1663265B1 (en) 2003-07-23 2015-09-23 Biocontrol Limited Bacteriophage-containing therapeutic agents
WO2006063176A2 (en) 2004-12-06 2006-06-15 The Government Of The Usa As Representedtd By The Secretary Of The Dept Of Health And Human Services Inhibition of biofilm formation using bacteriophage
KR100910961B1 (ko) 2007-09-13 2009-08-05 주식회사 인트론바이오테크놀로지 황색포도상구균의 균막 처치에 효과적인 박테리오파지 또는그것 유래의 용균단백질
WO2010141135A2 (en) 2009-03-05 2010-12-09 Trustees Of Boston University Bacteriophages expressing antimicrobial peptides and uses thereof

Also Published As

Publication number Publication date
WO2015065209A1 (en) 2015-05-07

Similar Documents

Publication Publication Date Title
TN2017000085A1 (en) Polypeptide having a polyester degrading activity and uses thereof
NZ730865A (en) Peptides having anti-inflammatory properties
EA201400836A1 (ru) Получение дитерпена
MY176331A (en) Carbohydrate degrading polypeptide and uses thereof
MX2017016811A (es) Metodos para mejorar el rendimiento del animal.
MX2017017018A (es) Composiciones de pienso para animales y usos de las mismas.
MX2022008508A (es) Enzimas y aplicaciones de las mismas.
MX352205B (es) Sistemas de expresion.
WO2014191359A9 (en) Aptamers and use of the aptamers in the diagnosis and treatment of cancer
EA201692031A1 (ru) Фармацевтическая композиция с активным действием в отношении хронических бактериальных инфекций
MY167231A (en) Amino acid sequences directed against IL-17A, IL-17F and/or IL17-A/F and polypeptides comprising the same
MX2014015002A (es) Polipeptidos que tienen actividad de transgalactosilacion.
PH12017501473A1 (en) Novel proteins specific for pyoverdine and pyochelin
EP3903823A3 (en) Antimicrobial peptides and methods of use thereof
MX2017009153A (es) Proteinas de fusion de citoquinas.
PE20220960A1 (es) Proteinas de variantes de secuencias de aminoacidos de cry1da1 activas para lepidopteros
EA201691011A1 (ru) Последовательность модифицированного эндолизина el188
NZ741342A (en) Daptomycin formulations and uses thereof
NZ706884A (en) Fc gamma receptor iib variants
MX2016006277A (es) Secuencia de endolisina kz144 modificada.
AR101555A1 (es) ANTICUERPOS DIRIGIDOS AL RECEPTOR IIB DE Fc g Y AL RECEPTOR DE Fc e
MX2018008545A (es) Composicion antibacteriana y metodo para tratar infecciones por estafilococos con la composicion antibacteriana.
MX2015001542A (es) Metodo.
NZ709120A (en) Beta-hexosyl-transferases and uses thereof
PE20160847A1 (es) Nuevo compuesto para el tratamiento de hipoglicemia severa